People · Operator
Named in public records as an officer, director or promoter · active 2007–2022 · Other, Computers, Biotech / Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MacKeyser Holdings, LLC | — | Other | Series B | $49.9M | $141.2M | 2011 |
| Carbon Design Systems Inc | — | Computers | Series A | $22.1M | $283.1M | 2007 |
| CASS Pharmaceuticals, Inc. | — | Biotech / Pharma | Seed | $2.1M | $25.9M | 2020 |
| Diakard, Inc. | — | Other Technology | Pre-Seed | $400K | $16.9M | 2020 |
Stephen McCormack at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen McCormack on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Solomon Steiner | 2 | 3 |
| David Smith | 1 | 42 |
| Adam Grossman | 1 | 5 |
| Stan Reiss | 1 | 5 |
| David Brailer | 1 | 4 |
| Stephen Ricci | 1 | 4 |
| Mark Edwards | 1 | 4 |
| Stephen J. McCormack | 1 | 2 |
| Richard Lucier | 1 | 2 |
| Allison McFarland | 1 | 1 |
| WILLIAM HERMAN | 1 | 1 |
| Jay Rose | 1 | 1 |
| Pierre J. Keyser | 1 | 1 |
| Pierre Keyser | 1 | 1 |
| Peter Dumas | 1 | 1 |
| Erica Perreira | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.